Potrero Medical
Hayward, US · Founded 2012 · Delaware corporation · 1 known investors
Founders & leadership
Potrero Medical was founded in 2012 by Daniel Burnett.
DB
Daniel BurnettFounder
SB
Sanjay BanerjeeChief Executive Officer
RK
Rich KeenanChief Product Officer
JU
Joe UrbanExecutive
Board
CD
Christopher DeweyBoard director
MG
Mark GoldwasserBoard director
AC
Alan CheslerBoard director
CW
Colby WoodBoard director
AO
Andrew OfferBoard director
MF
Maurice FerreBoard director
RR
Ramachandra ReddyBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$82.7M disclosed across 8 rounds · 2014–2026
▶$6.5MraisedMay 2026 · 56 investors · BiotechnologyRule 506(c)
▶$6.5MraisedMay 2026 · 56 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Mark GoldwasserDirector
- Ram ReddyDirector
- Rich KeenanExecutive Officer
- Maurice FerreDirector
- Todd DunnExecutive Officer
- Mike StanskyDirector
- David MatlinDirector
- Khalid GhafariExecutive Officer
- Christopher DeweyDirector
- Clay HeightenDirector
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- Minimum investment
- $1.3K
- Sales commissions
- $650K
- Placement agents
- Ceros Financial Services, Inc.
- First sale
- May 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$2.3MraisedSep 2025 · 29 investors · BiotechnologyRule 506(b)
▶$2.3MraisedSep 2025 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Maurice FerreDirector
- Ramachandra ReddyDirector
- Mark GoldwasserDirector
- Chad ZaringDirector
- Todd DunnExecutive Officer, Director
- Christopher DeweyDirector
- Rich KeenanExecutive Officer
- Offering amount
- $5.5M
- Amount sold
- $2.3M
- Sales commissions
- $500K
- Placement agents
- Ceros Financial Services, Inc.
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.2MraisedOct 2024 · 6 investors · BiotechnologyRule 506(b)
▶$3.2MraisedOct 2024 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Maurice FerreDirector
- Sanjay BanerjeeExecutive Officer
- Ramachandra ReddyDirector
- Rich KeenanExecutive Officer
- Christopher DeweyDirector
- Mark GoldwasserDirector
- Offering amount
- $12M
- Amount sold
- $3.2M
- Minimum investment
- $50K
- Sales commissions
- $1.2M
- Placement agents
- Ceros Financial Services, Inc.
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$17.7MraisedApr 2023 · 99 investors · BiotechnologyRule 506(b)
▶$17.7MraisedApr 2023 · 99 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alan CheslerDirector
- Daniel BurnettDirector
- Colby WoodDirector
- Joe UrbanExecutive Officer, Director
- Andrew OfferDirector
- Offering amount
- $24.6M
- Amount sold
- $17.7M
- Minimum investment
- $1
- Sales commissions
- $480K
- Placement agents
- Ceros Financial Services, Inc.
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$17.2MraisedOct 2019 · 26 investors · BiotechnologyRule 506(b)
▶$17.2MraisedOct 2019 · 26 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jay WatkinsDirector
- Alan CheslerDirector
- Carter MeyerDirector
- Joe UrbanExecutive Officer, Director
- Daniel BurnettDirector
- Frederic H. MollDirector
- Offering amount
- $20M
- Amount sold
- $17.2M
- Minimum investment
- $1
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$24.6MraisedJul 2018 · 32 investors · BiotechnologyRule 506(b)
▶$24.6MraisedJul 2018 · 32 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alan CheslerDirector
- Carter MeyerDirector
- David GreenbergDirector
- Daniel BurnettExecutive Officer, Director
- Joe UrbanExecutive Officer
- George RapierDirector
- Offering amount
- $31.3M
- Amount sold
- $24.6M
- Minimum investment
- $1
- First sale
- May 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.3MraisedAug 2017 · 21 investors · BiotechnologyRule 506(b)
▶$7.3MraisedAug 2017 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Urban JoeDirector
- Alan CheslerDirector
- Carter MeyerDirector
- George RapierDirector
- David GreenbergDirector
- Daniel BurnettExecutive Officer, Director
- Offering amount
- $12.1M
- Amount sold
- $7.3M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$3.9MraisedMay 2014 · 9 investors · BiotechnologyRule 506(c)
▶$3.9MraisedMay 2014 · 9 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Daniel BurnettExecutive Officer
- Offering amount
- $3.9M
- Amount sold
- $3.9M
- Minimum investment
- $12.5K
- Sales commissions
- $273K
- Placement agents
- Gordian Investments, LLC, Gordian Investments, LLC, Gordian Investments, LLC, Ehrenberg Chesler Securities, Inc.
- First sale
- May 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Potrero Medical?
- Potrero Medical was founded by Daniel Burnett in 2012.
- Who are Potrero Medical's investors?
- Potrero Medical's investors include Inspire Global Ventures.
- How much funding has Potrero Medical raised?
- Potrero Medical has disclosed $82.7M raised across 8 rounds.
- Where is Potrero Medical headquartered?
- Potrero Medical is headquartered in Hayward, US.